Financhill
Back

Biomarin Pharmaceutical Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
54

BMRN
Biomarin Pharmaceutical

Last Price:
66.06
Seasonality Move:
13.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Biomarin Pharmaceutical Stock Forecast

  • Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 12.9% based on the past 25 years of stock performance.
  • Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Biomarin Pharmaceutical Stock Undervalued?
    The current Biomarin Pharmaceutical [BMRN] share price is $66.04. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Biomarin Pharmaceutical Stock Go Up Next Year?

  • Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 12.9% based on the past 25 years of stock performance.

Biomarin Pharmaceutical Stock Rating

Buy
54
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical overpriced?

  • Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Biomarin Pharmaceutical Stock Price History

Is BMRN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com

52-Week Data

52-Week High:
99.56
52-Week Low:
65.35

Prediction Charts

Market Cap:
12.59B
Price in USD:
66.04
Volume:
1.61M
Beta:
0.88

Technical Analysis

SMA50:
74.56
SMA100:
80.05
SMA200:
82.71
52-Wk Change:
-17.02%

Stock Predictions

  • Is Biomarin Pharmaceutical stock public?
    Yes, Biomarin Pharmaceutical is a publicly traded company.
  • What is the Biomarin Pharmaceutical stock quote today?
    The Biomarin Pharmaceutical stock price is 66.04 USD today.
  • How to buy Biomarin Pharmaceutical stock online?
    You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 70.24 70.16 70.90 69.94
Oct-18 69.70 70.11 70.13 69.29
Oct-21 69.99 70.28 70.81 69.56
Oct-22 69.72 70.53 70.74 69.50
Oct-23 70.23 69.98 70.37 69.40
Oct-24 70.05 70.39 70.98 69.58
Oct-25 70.68 69.73 70.98 69.66
Oct-28 69.92 70.13 70.71 69.60
Oct-29 69.78 69.92 70.56 69.20
Oct-30 69.67 66.68 69.67 65.78
Oct-31 66.68 65.87 66.92 65.35
Nov-1 65.70 66.60 66.81 65.60
Nov-4 66.24 66.00 66.59 65.56
Nov-5 66.23 66.04 66.23 65.45

Biomarin Pharmaceutical Earnings

Biomarin Pharmaceutical Earnings Report: Per Share Biomarin Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.

Biomarin Pharmaceutical Forecast Revenue Growth

Biomarin Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Biomarin Pharmaceutical and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.

* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.